These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35096128)

  • 21. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.
    Chen H; Tran D; Yang HC; Nylander S; Birnbaum Y; Ye Y
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):443-461. PubMed ID: 32335797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced
    Hodrea J; Balogh DB; Hosszu A; Lenart L; Besztercei B; Koszegi S; Sparding N; Genovese F; Wagner LJ; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F1017-F1029. PubMed ID: 32116017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dihydromyricetin improves cardiac insufficiency by inhibiting HMGB1 in diabetic rats].
    Liu S; Liu Q; Peng Q; Zhang Y; Wang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):641-648. PubMed ID: 35673906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2α signaling pathway in arrhythmogenic cardiomyopathy.
    Yang Z; Li T; Xian J; Chen J; Huang Y; Zhang Q; Lin X; Lu H; Lin Y
    FASEB J; 2022 Jul; 36(7):e22410. PubMed ID: 35713937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lycium barbarum polysaccharide attenuates cardiac hypertrophy, inhibits calpain-1 expression and inhibits NF-κB activation in streptozotocin-induced diabetic rats.
    Liu Q; Han Q; Lu M; Wang H; Tang F
    Exp Ther Med; 2019 Jul; 18(1):509-516. PubMed ID: 31258688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload.
    Shi L; Zhu D; Wang S; Jiang A; Li F
    Am J Hypertens; 2019 Apr; 32(5):452-459. PubMed ID: 30689697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL/6NCrl mice with high-fat diet/streptozotocin-induced diabetes mellitus.
    Belosludtsev KN; Starinets VS; Belosludtsev MN; Mikheeva IB; Dubinin MV; Belosludtseva NV
    Mitochondrion; 2021 Jul; 59():246-254. PubMed ID: 34144205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
    Shao Q; Meng L; Lee S; Tse G; Gong M; Zhang Z; Zhao J; Zhao Y; Li G; Liu T
    Cardiovasc Diabetol; 2019 Nov; 18(1):165. PubMed ID: 31779619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats.
    Wang XT; Gong Y; Zhou B; Yang JJ; Cheng Y; Zhao JG; Qi MY
    Biomed Pharmacother; 2018 Jan; 97():1461-1467. PubMed ID: 29156537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sodium hydrosulfide attenuates myocardial injury through activating thioredoxin system in diabetic rats].
    Jia Q; Yang R; Liu X; Wang Q; Lu H; Ma S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1385-1391. PubMed ID: 29169424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model.
    Wu B; Huang XY; Li L; Fan XH; Li PC; Huang CQ; Xiao J; Gui R; Wang S
    J Cell Mol Med; 2019 Nov; 23(11):7651-7663. PubMed ID: 31565849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-κB activation in human endothelial cells and differentiated macrophages.
    Abdollahi E; Keyhanfar F; Delbandi AA; Falak R; Hajimiresmaiel SJ; Shafiei M
    Eur J Pharmacol; 2022 Mar; 918():174715. PubMed ID: 35026193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Icariin Attenuates Diabetic Cardiomyopathy and Downregulates Extracellular Matrix Proteins in Heart Tissue of Type 2 Diabetic Rats.
    Qiao C; Wang H; Song Z; Ding Y; Tao J; Aa J; Ding X
    Pharmacology; 2020; 105(9-10):576-585. PubMed ID: 32097949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling.
    Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y
    J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats.
    Durak A; Olgar Y; Degirmenci S; Akkus E; Tuncay E; Turan B
    Cardiovasc Diabetol; 2018 Nov; 17(1):144. PubMed ID: 30447687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway.
    Wang M; Zhang WB; Zhu JH; Fu GS; Zhou BQ
    Acta Pharmacol Sin; 2009 Aug; 30(8):1081-91. PubMed ID: 19597526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-κB signaling pathways.
    Tang SG; Liu XY; Ye JM; Hu TT; Yang YY; Han T; Tan W
    J Endocrinol; 2018 Jul; 238(1):47-60. PubMed ID: 29720537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dapagliflozin Improves Cardiac Hemodynamics and Mitigates Arrhythmogenesis in Mitral Regurgitation-Induced Myocardial Dysfunction.
    Lin YW; Chen CY; Shih JY; Cheng BC; Chang CP; Lin MT; Ho CH; Chen ZC; Fisch S; Chang WT
    J Am Heart Assoc; 2021 Apr; 10(7):e019274. PubMed ID: 33749310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
    Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
    Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.